MapLight Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MPLT and other ETFs, options, and stocks.

About MPLT

MapLight Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics for brain disorders. It develops the ML-007-MA product for treatment of schizophrenia and ADP. 

CEO
Christopher A. Kroeger
CEOChristopher A. Kroeger
Employees
133
Employees133
Headquarters
Redwood City, California
HeadquartersRedwood City, California
Founded
2018
Founded2018
Employees
133
Employees133

MPLT Key Statistics

Market cap
1.18B
Market cap1.18B
Price-Earnings ratio
-7.52
Price-Earnings ratio-7.52
Dividend yield
Dividend yield
Average volume
366.59K
Average volume366.59K
High today
$29.24
High today$29.24
Low today
$27.76
Low today$27.76
Open price
$29.00
Open price$29.00
Volume
212.35K
Volume212.35K
52 Week high
$33.28
52 Week high$33.28
52 Week low
$12.24
52 Week low$12.24

Stock Snapshot

With a market cap of 1.18B, MapLight Therapeutics(MPLT) trades at $27.92. The stock has a price-to-earnings ratio of -7.52.

During the trading session on 2026-05-06, MapLight Therapeutics(MPLT) shares reached a daily high of $29.24 and a low of $27.76. At a current price of $27.92, the stock is +0.6% higher than the low and still -4.5% under the high.

Trading volume for MapLight Therapeutics(MPLT) stock has reached 212.35K, versus its average volume of 366.59K.

The stock's 52-week range extends from a low of $12.24 to a high of $33.28.

The stock's 52-week range extends from a low of $12.24 to a high of $33.28.

Analyst ratings

100%

of 8 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own MPLT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.